Search results
Found 30795 matches for
A new study by researchers at NDORMS, University of Oxford now published in Osteoarthritis and Cartilage found that the average lifetime risk of needing further surgery following knee and hip replacement – revision surgery – was around 5% after knee replacement and 8% after hip replacement, with neither body mass index (BMI, combining an individual's height and weight) or smoking having any meaningful effect on these risks.
Trials Expertise Session: Effective planning and management of trial sample collections
Tuesday, 04 November 2025, 10.30am to 11.30am
Trials Expertise Session: The role of a Trial Manager in a Trial Management Group (TMG) *online*
Thursday, 12 June 2025, 10am to 11am
Trials Expertise Session: Communication skills in Clinical Trials for Trial Managers *online*
Wednesday, 26 March 2025, 10am to 11am
Trials Expertise Session: Site Feasibility Questionnaires (SFQ) & Site selection *Hybrid*
Wednesday, 25 June 2025, 11am to 12pm
Meet the team
-
Ed Burn
Senior Researcher in Epidemiology and Health Economics
-
Daniel Prieto-Alhambra
Professor of Pharmaco- and Device Epidemiology
-
Rafael Pinedo Villanueva
Associate Professor
-
David Murray
Professor of Orthopaedic Surgery
-
Cyrus Cooper
Professor of Musculoskeletal Science, University of Oxford
Funder
Read the paper
The impact of bmi and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data
Osteoarthritis and Cartilage, May 2019